CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy
Calmare is being used to treat international patients in Italy, India, Greece, Bangladesh, and U.S. patients at clinics in Utah, Texas, Massachusetts, New York, Virginia, Florida, Connecticut and Rhode Island. In addition to treating pain associated with cancer and cancer treatments, Calmare Pain Therapy also successfully treats chronic neuropathic pain resulting from shingles, failed back surgery, phantom limb syndrome, sciatica, spinal stenosis and other maladies.
CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN
Competitive Technologies, Inc. (NYSE Amex:CTT) today announced the issuance of an abstract from a study which has shown the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTT's Calmare® Pain Therapy Treatment.
Emerging Chronic Pain Device Improving Lives
The Calmare scrambler is most often used for chemotherapy-induced peripheral neuropathy, which causes sensations of burning, numbness, aching, coldness, itching, and tingling. However, Calmare is also being used to treat other chronic pain conditions, including lower back pain, neck pain, diabetic pain, fibromyalgia, post-surgical pain, RSD (Reflex Sympathetic Dystrophy), and radiating pain.
Survey Finds Many Suffering Needlessly from Neuropathic Pain
A national survey of peripheral neuropathy patients found that over half took at least two years before they received the right diagnosis from their doctors. Many also receive inadequate pain care and go through distressing life changes.
Scrambler Therapy May Relieve Chronic Neuropathic Pain More Effectively Than Guideline-Based Drug Management: Results of a Pilot, Randomized, Controlled Trial
In this pilot randomized trial, Scrambler therapy appeared to relieve chronic neuropathic pain better than guideline-based drug management.
The pain system is characterized by a high level of information content. Specific receptors, mechanoceptors and multimodal receptors, respond indifferently to all painful stimuli...
Pilot Trial of a Patient-Specific Cutaneous Electrostimulation Device (MC5-A Calmare®) for Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is a major, often dose-limiting and persistent consequence of numerous classes of antineoplastic agents.
Untreatable Pain Resulting from Abdominal Cancer: New Hope from Biophysics
Visceral pain characterizing pancreatic cancer is the most difficult symptom of the disease to control and can significantly impair the quality of life which remains and increase the demand for euthanasia.